# Bridge Pharma (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/bridge-pharma-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 33 |
| Citations | 35,276 |
| City | Sarasota |
| Country | US |
| Description | Bridge Pharma (United States) is a research organisation in Sarasota, US. OpenAlex records 1,267 works and 35,276 citations for it. 608 researchers list it as their most recent affiliation. |
| Homepage | http://bridgepharma.com/ |
| OpenAlex ID | https://openalex.org/I4210160593 |
| Region | Florida |
| Researchers | 608 |
| ROR ID | https://ror.org/05psz3234 |
| Type | company |
| Works | 1,267 |

## University papers

- [The relationship between cognition and functioning in schizophrenia: A semi-systematic review](https://scholariq.org/papers/the-relationship-between-cognition-and-functioning-in-schizophrenia-a-semi/)
- [The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review](https://scholariq.org/papers/the-clinical-humanistic-and-economic-burden-of-generalized-pustular-psoriasis-a/)
- [Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations](https://scholariq.org/papers/successful-use-of-maintenance-rtms-for-8-months-in-a-patient-with-antipsychotic/)
- [A systematic review of seizure clusters: Prevalence, risk factors, burden of disease and treatment patterns](https://scholariq.org/papers/a-systematic-review-of-seizure-clusters-prevalence-risk-factors-burden-of/)
- [Informed consent in psychiatry clinical research: A conceptual review of issues, challenges, and recommendations](https://scholariq.org/papers/informed-consent-in-psychiatry-clinical-research-a-conceptual-review-of-issues/)
- [Challenges With the Use of Digital Sham: Systematic Review and Recommendations](https://scholariq.org/papers/challenges-with-the-use-of-digital-sham-systematic-review-and-recommendations-2/)
- [<p>Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting</p>](https://scholariq.org/papers/and-lt-p-and-gt-connected-drug-delivery-devices-to-complement-drug-treatments/)
- [The clinical, humanistic, and economic burden of palmoplantar pustulosis: a structured review](https://scholariq.org/papers/the-clinical-humanistic-and-economic-burden-of-palmoplantar-pustulosis-a/)
- [Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review](https://scholariq.org/papers/health-related-quality-of-life-fatigue-and-health-utilities-in-lupus-nephritis-a/)
- [Challenges in conducting psychiatry studies in India](https://scholariq.org/papers/challenges-in-conducting-psychiatry-studies-in-india/)

## University researchers

- [Saifuddin Kharawala](https://scholariq.org/researchers/saifuddin-kharawala/)

## University top topics

Showing 8 of 24.

- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Structural Engineering and Vibration Analysis](https://scholariq.org/topics/structural-engineering-and-vibration-analysis/)
- [Structural Load-Bearing Analysis](https://scholariq.org/topics/structural-load-bearing-analysis/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Geotechnical Engineering and Underground Structures](https://scholariq.org/topics/geotechnical-engineering-and-underground-structures/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.